June 13, 2012 — Physicians presented at EuroPCR 2012 the results of two multicenter, randomized controlled trials, the BELLO and PACIFIER studies, each one showing statistically significant advantages of using an IN.PACT drug-eluting balloon from Medtronic Inc. over a corresponding conventional treatment for coronary and peripheral artery disease (CAD and PAD), respectively.

June 13, 2012 — AliveCor announced it has raised $10.5 million in Series B venture financing. The financing comes on the heels of recent presentations at major cardiology conferences, in which supporting data demonstrated the clinical utility and accuracy of AliveCor's device in monitoring patients' heart health.

June 13, 2012 — Positron Corp. announced completion of its first strontium validation effort in May 2012, when Manhattan Isotope Technology (MIT), a Positron subsidiary, successfully processed strontium.


As the nation’s leading provider of maternal-fetal, newborn and pediatric subspecialty physician services, Pediatrix Medical Group says streamlining the transfer of images and reports is a priority. Seeking a faster, more reliable method of exchanging files than on CD, the group adopted a cloud-based medical information exchange. 

 

 

Best Cyclotron Systems is unveiling five new cyclotrons for isotope research and production at the Society of Nuclear Medicine (SNM) 2012 Annual Meeting on June 9-12 in Miami Beach, Fla.

Boston Scientific Corporation has closed its acquisition of Cameron Health and, as a result, added to its product portfolio the world's first and only commercially available subcutaneous implantable cardioverter defibrillator, called the S-ICD System. 

June 11, 2012 — Boehringer Ingelheim Pharmaceuticals Inc. announced that the Pradaxa (dabigatran etexilate mesylate) capsules prescribing information has been updated to affirm that "Pradaxa 150 mg twice daily was superior in reducing ischemic and hemorrhagic strokes relative to warfarin."

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now